Identification of six cardiovascular risk biomarkers in the young population: A promising tool for early prevention

dc.contributor.authorMartínez, Paula J.
dc.contributor.authorBaldán Martín, Montserrat
dc.contributor.authorLópez, Juan Antonio
dc.contributor.authorMartín Lorenzo, Marta
dc.contributor.authorSantiago Hernández, Aranzazu
dc.contributor.authorAgudiez, Marta
dc.contributor.authorCabrera, Martha
dc.contributor.authorBarderas, María G.
dc.contributor.authorÁlvarez Llamas, Gloria
dc.contributor.authorRuilope Urioste, Luis Miguel
dc.contributor.authorEt al.
dc.date.accessioned2019-03-18T10:51:11Z
dc.date.available2019-03-18T10:51:11Z
dc.date.issued2019
dc.description.abstractBackground and aims: The predictive value of traditional CV risk calculators is limited. Novel indicators of CVD progression are needed particularly in the young population. The main aim of this study was the identification of a molecular profile with added value to classical CV risk estimation. Methods: Eighty-one subjects (30-50 years) were classified in 3 groups according to their CV risk: healthy subjects; individuals with CV risk factors; and those who had suffered a previous CV event. The urine proteome was quantitatively analyzed and significantly altered proteins were identified between patients' groups, either related to CV risk or established organ damage. Target-MS and ELISA were used for confirmation in independent patients' cohorts. Systems Biology Analysis (SBA) was carried out to identify functional categories behind CVD. Results: 4309 proteins were identified, 75 of them differentially expressed. ADX, ECP, FETUB, GDF15, GUAD and NOTCH1 compose a fingerprint positively correlating with lifetime risk estimate (LTR QRISK). Best performance ROC curve was obtained when ECP, GDF15 and GUAD were combined (AUC = 0.96). SBA revealed oxidative stress response, dilated cardiomyopathy, signaling by Wnt and proteasome, as main functional processes related to CV risk. Conclusions: A novel urinary protein signature is shown, which correlates with CV risk estimation in young individuals. Pending further confirmation, this six-protein-panel could help in CV risk assessment.spa
dc.description.filiationUEMspa
dc.description.impact3.919 JCR (2019) Q1, 16/65 Peripheral Vascular Disease; Q2, 42/138 Cardiac & Cadiovascular Systemsspa
dc.description.impact1.515 SJR (2019) Q1, 51/362 Cardiology and Cardiovascular Medicinespa
dc.description.impactNo data IDR 2019spa
dc.description.sponsorshipFEDER (PI14/01650, PI14/01917, PI14/01841, PI16/01334, IF08/3667-1, FI12/00126, CPII15/00027, CP15/00129, PT13/0001/0013, PI17/01093, PI17/01193, IPT17/0019, ISCIIIS-GEFI/ERDF, RD12/0021/0001, RD16/0009)spa
dc.description.sponsorshipFundacion SENEFROspa
dc.description.sponsorshipFundacion Inigo Alvarez de Toledospa
dc.description.sponsorshipFundacion Conchita Rabago de Jimenez Diazspa
dc.identifier.citationMartínez, P. J., Baldán-Martín, M., López, J. A., Martín-Lorenzo, M., Santiago-Hernández, A., Agudiez, M., ... & Vivanco, F. (2019). Identification of six cardiovascular risk biomarkers in the young population: A promising tool for early prevention. Atherosclerosis, 282, 67-74. http://doi.org/10.1016/j.atherosclerosis.2019.01.003spa
dc.identifier.doi10.1016/j.atherosclerosis.2019.01.003
dc.identifier.issn0021-9150
dc.identifier.issn1879-1484
dc.identifier.urihttp://hdl.handle.net/11268/7846
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessspa
dc.subject.uemCardiopatía coronariaspa
dc.subject.unescoEnfermedad cardiovascularspa
dc.titleIdentification of six cardiovascular risk biomarkers in the young population: A promising tool for early preventionspa
dc.typejournal articlespa
dspace.entity.typePublication

Files